{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:17:02Z","timestamp":1773058622450,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,1,28]]},"DOI":"10.1038\/onc.2015.101","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T19:26:02Z","timestamp":1429557962000},"page":"468-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance"],"prefix":"10.1038","volume":"35","author":[{"given":"Y","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A C","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B S","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M N","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D K","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B G","family":"Hollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T F","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G E","family":"Konecny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Winterhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N P","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Crandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N B","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A V","family":"Tinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C B","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J I","family":"Coward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J W","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L C","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Armes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,20]]},"reference":[{"key":"BFonc2015101_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2015101_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/bjc.2013.126","volume":"108","author":"DS Tan","year":"2013","unstructured":"Tan DS, Miller RE, Kaye SB . New perspectives on molecular targeted therapy in ovarian clear cell carcinoma. Br J Cancer 2013; 108: 1553\u20131559.","journal-title":"Br J Cancer"},{"key":"BFonc2015101_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","volume":"109","author":"JK Chan","year":"2008","unstructured":"Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS . Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008; 109: 370\u2013376.","journal-title":"Gynecol Oncol"},{"key":"BFonc2015101_CR4","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000; 88: 2584\u20132589.","journal-title":"Cancer"},{"key":"BFonc2015101_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2011.03.011","volume":"122","author":"J Al-Barrak","year":"2011","unstructured":"Al-Barrak J, Santos JL, Tinker A, Hoskins P, Gilks CB, Lau H et al. Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma. Gynecol Oncol 2011; 122: 107\u2013110.","journal-title":"Gynecol Oncol"},{"key":"BFonc2015101_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1200\/JCO.2011.40.1646","volume":"30","author":"PJ Hoskins","year":"2012","unstructured":"Hoskins PJ, Le N, Gilks B, Tinker A, Santos J, Wong F et al. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol 2012; 30: 1656\u20131662.","journal-title":"J Clin Oncol"},{"key":"BFonc2015101_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E . Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053\u20131064.","journal-title":"Am J Pathol"},{"key":"BFonc2015101_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB . Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 2006; 7: 925\u2013934.","journal-title":"Lancet Oncol"},{"key":"BFonc2015101_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/iub.198","volume":"61","author":"A Wortmann","year":"2009","unstructured":"Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD . The cell surface glycoprotein CDCP1 in cancer\u2014insights, opportunities, and challenges. IUBMB Life 2009; 61: 723\u2013730.","journal-title":"IUBMB Life"},{"key":"BFonc2015101_CR10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/0008-5472.CAN-12-2496","volume":"73","author":"DS Spassov","year":"2013","unstructured":"Spassov DS, Wong CH, Wong SY, Reiter JF, Moasser MM . Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells. Cancer Res 2013; 73: 1168\u20131179.","journal-title":"Cancer Res"},{"key":"BFonc2015101_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nbt.1644","volume":"28","author":"T Tang","year":"2010","unstructured":"Tang T, Li L, Tang J, Li Y, Lin WY, Martin F et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 2010; 28: 749\u2013755.","journal-title":"Nat Biotechnol"},{"key":"BFonc2015101_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00432-008-0412-4","volume":"134","author":"Y Awakura","year":"2008","unstructured":"Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T et al. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol 2008; 134: 1363\u20131369.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc2015101_CR13","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1073\/pnas.1222435110","volume":"110","author":"BM Emerling","year":"2013","unstructured":"Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H et al. Identification of CDCP1 as a hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) target gene that is associated with survival in clear cell renal cell carcinoma patients. Proc Natl Acad Sci USA 2013; 110: 3483\u20133488.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015101_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.gastro.2013.05.049","volume":"145","author":"W Gao","year":"2013","unstructured":"Gao W, Chen L, Ma Z, Du Z, Zhao Z, Hu Z et al. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gastroenterology 2013; 145: 636\u201346 e5.","journal-title":"Gastroenterology"},{"key":"BFonc2015101_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1349-7006.2008.01066.x","volume":"100","author":"J Ikeda","year":"2009","unstructured":"Ikeda J, Oda T, Inoue M, Uekita T, Sakai R, Okumura M et al. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 2009; 100: 429\u2013433.","journal-title":"Cancer Sci"},{"key":"BFonc2015101_CR16","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/0008-5472.CAN-10-0220","volume":"70","author":"Y Miyazawa","year":"2010","unstructured":"Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y et al. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 2010; 70: 5136\u20135146.","journal-title":"Cancer Res"},{"key":"BFonc2015101_CR17","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.1011777108","volume":"108","author":"OV Razorenova","year":"2011","unstructured":"Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK et al. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC\u03b4-driven migration. Proc Natl Acad Sci USA 2011; 108: 1931\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015101_CR18","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/onc.2011.555","volume":"31","author":"B Casar","year":"2012","unstructured":"Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI . Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene 2012; 31: 3924\u20133938.","journal-title":"Oncogene"},{"key":"BFonc2015101_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/1541-7786.MCR-09-0100","volume":"7","author":"EI Deryugina","year":"2009","unstructured":"Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC et al. Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. Mol Cancer Res 2009; 7: 1197\u20131211.","journal-title":"Mol Cancer Res"},{"key":"BFonc2015101_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/onc.2012.547","volume":"33","author":"B Casar","year":"2014","unstructured":"Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI . In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated beta1 integrin and induction of FAK\/PI3K\/Akt motility signaling. Oncogene 2014; 33: 255\u2013268.","journal-title":"Oncogene"},{"key":"BFonc2015101_CR21","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1073\/pnas.1017228108","volume":"108","author":"H Liu","year":"2011","unstructured":"Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO . CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 2011; 108: 1379\u20131384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015101_CR22","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2174\/138945012803530044","volume":"13","author":"RY Huang","year":"2012","unstructured":"Huang RY, Chung VY, Thiery JP . Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets 2012; 13: 1649\u20131653.","journal-title":"Curr Drug Targets"},{"key":"BFonc2015101_CR23","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M111.335448","volume":"287","author":"Y Dong","year":"2012","unstructured":"Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA et al. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration. J Biol Chem 2012; 287: 9792\u20139803.","journal-title":"J Biol Chem"},{"key":"BFonc2015101_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.onc.1206220","volume":"22","author":"JD Hooper","year":"2003","unstructured":"Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135\/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 2003; 22: 1783\u20131794.","journal-title":"Oncogene"},{"key":"BFonc2015101_CR25","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.1128\/MCB.01246-07","volume":"27","author":"T Uekita","year":"2007","unstructured":"Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R . CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol 2007; 27: 7649\u20137660.","journal-title":"Mol Cell Biol"},{"key":"BFonc2015101_CR26","first-page":"45","volume":"5","author":"Z Kemp","year":"2013","unstructured":"Kemp Z, Ledermann J . Update on first-line treatment of advanced ovarian carcinoma. Int J Womens Health 2013; 5: 45\u201351.","journal-title":"Int J Womens Health"},{"key":"BFonc2015101_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1349-7006.2002.tb01312.x","volume":"93","author":"H Itamochi","year":"2002","unstructured":"Itamochi H, Kigawa J, Sultana H, Iba T, Akeshima R, Kamazawa S et al. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. Jpn J Cancer Res 2002; 93: 723\u2013728.","journal-title":"Jpn J Cancer Res"},{"key":"BFonc2015101_CR28","first-page":"1299","volume":"20","author":"Y Saga","year":"2008","unstructured":"Saga Y, Ohwada M, Suzuki M, Konno R, Kigawa J, Ueno S et al. Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. Oncol Rep 2008; 20: 1299\u20131303.","journal-title":"Oncol Rep"},{"key":"BFonc2015101_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ygyno.2005.02.006","volume":"98","author":"JA Smith","year":"2005","unstructured":"Smith JA, Ngo H, Martin MC, Wolf JK . An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol Oncol 2005; 98: 141\u2013145.","journal-title":"Gynecol Oncol"},{"key":"BFonc2015101_CR30","doi-asserted-by":"publisher","first-page":"42303","DOI":"10.1074\/jbc.M111.227462","volume":"286","author":"A Wortmann","year":"2011","unstructured":"Wortmann A, He Y, Christensen ME, Linn M, Lumley JW, Pollock PM et al. Cellular settings mediating Src substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734. J Biol Chem 2011; 286: 42303\u201342315.","journal-title":"J Biol Chem"},{"key":"BFonc2015101_CR31","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1158\/1078-0432.CCR-08-2533","volume":"15","author":"CH Wong","year":"2009","unstructured":"Wong CH, Baehner FL, Spassov DS, Ahuja D, Wang D, Hann B et al. Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers. Clin Cancer Res 2009; 15: 2311\u20132322.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015101_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbagen.2008.01.010","volume":"1780","author":"SM Alvares","year":"2008","unstructured":"Alvares SM, Dunn CA, Brown TA, Wayner EE, Carter WG . The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140\/CDCP1. Biochim Biophys Acta 2008; 1780: 486\u2013496.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2015101_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjd.12119","volume":"168","author":"JA McGovern","year":"2013","unstructured":"McGovern JA, Heinemann JR, Burke LJ, Dawson R, Parker TJ, Upton Z et al. Stratum basale keratinocyte expression of the cell-surface glycoprotein CDCP1 during epidermogenesis and its role in keratinocyte migration. Br J Dermatol 2013; 168: 496\u2013503.","journal-title":"Br J Dermatol"},{"key":"BFonc2015101_CR34","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-07-1657","volume":"68","author":"AC Siva","year":"2008","unstructured":"Siva AC, Wild MA, Kirkland RE, Nolan MJ, Lin B, Maruyama T et al. Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model. Cancer Res 2008; 68: 3759\u20133766.","journal-title":"Cancer Res"},{"key":"BFonc2015101_CR35","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.molonc.2013.08.009","volume":"7","author":"G Kollmorgen","year":"2013","unstructured":"Kollmorgen G, Niederfellner G, Lifke A, Spohn GJ, Rieder N, Vega Harring S et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol 2013; 7: 1142\u20131151.","journal-title":"Mol Oncol"},{"key":"BFonc2015101_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/onc.2014.88","volume":"34","author":"MN Adams","year":"2014","unstructured":"Adams MN, Harrington BS, He Y, Davies CM, Wallace SJ, Chetty NP et al. EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface. Oncogene 2014; 34: 1375\u20131383.","journal-title":"Oncogene"},{"key":"BFonc2015101_CR37","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","volume":"159","author":"RC Casey","year":"2001","unstructured":"Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE et al. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 2001; 159: 2071\u20132080.","journal-title":"Am J Pathol"},{"key":"BFonc2015101_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1349-7006.2007.00722.x","volume":"99","author":"X Yu","year":"2008","unstructured":"Yu X, Liu L, Cai B, He Y, Wan X . Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci 2008; 99: 543\u2013552.","journal-title":"Cancer Sci"},{"key":"BFonc2015101_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.yexcr.2013.11.011","volume":"320","author":"L Carduner","year":"2014","unstructured":"Carduner L, Picot CR, Leroy-Dudal J, Blay L, Kellouche S, Carreiras F . Cell cycle arrest or survival signaling through alphav integrins, activation of PKC and ERK1\/2 lead to anoikis resistance of ovarian cancer spheroids. Exp Cell Res 2014; 320: 329\u2013342.","journal-title":"Exp Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:39:12Z","timestamp":1647895152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,1,28]]}},"alternative-id":["BFonc2015101"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.101","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,20]]},"assertion":[{"value":"22 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JDH is an inventor on a patent describing CDCP1 as an anti-cancer target. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}